Compare $RGNX vs $STTK | Chartloom

Compare

$RGNX vs $STTK

Regenxbio Inc · Shattuck Labs Inc

RGNX

Regenxbio Inc

STTK

Shattuck Labs Inc

Compare $RGNX vs $STTK

Comparing Regenxbio Inc and Shattuck Labs Inc

RGNXRegenxbio Inc

STTKShattuck Labs Inc

RGNXRegenxbio Inc

Market cap

$511M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.95x

Rev growth (TTM)

12.0%

YTD performance

-40.5%

52W performance

-34.0%

FCF yield

-48.9%

STTKShattuck Labs Inc

Market cap

$540M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-66.6%

YTD performance

60.9%

52W performance

149.8%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RGNX

STTK

Detailed metrics comparison

RGNX

Regenxbio Inc

STTK

Shattuck Labs Inc

Market Cap

RGNX$511M

STTK$540M

Enterprise Value

RGNX$656M

STTK$476M

Price

RGNX$8.07

STTK$5.97

P/E Ratio

RGNXN/A

STTKN/A

P/S Ratio

RGNX2.93x

STTK539.51x

EV/Sales

RGNX3.76x

STTK476.21x

EV/EBITDA

RGNX5.30x

STTK0.00x

P/B Ratio

RGNX6.83x

STTK3.20x

P/FCF Ratio

RGNXN/A

STTKN/A

EV/FCF

RGNX-2.63x

STTK-11.55x

PEG Ratio

RGNXN/A

STTKN/A

Forward P/E (NTM)

RGNXN/A

STTKN/A

Forward P/S (NTM)

RGNX5.95x

STTKN/A

Revenue (TTM)

RGNX$174M

STTK$1M

Revenue Growth (YoY)

RGNX12.0%

STTK-66.6%

Forward Rev Growth

RGNX25.9%

STTK118.7%

Gross Margin (TTM)

RGNX86.4%

STTK0.0%

Operating Margin (TTM)

RGNX0.0%

STTK0.0%

EBITDA Margin (TTM)

RGNX-85.3%

STTK-5212.2%

Net Margin (TTM)

RGNX-112.6%

STTK-5256.8%

FCF Margin (TTM)

RGNX-143.1%

STTK-4124.0%

Net Income (TTM)

RGNX$-196M

STTK$-53M

FCF (TTM)

RGNX$-250M

STTK$-41M

EPS (TTM)

RGNX-$3.71

STTK-$0.41

ROE (TTM)

RGNX-22007.0%

STTK-4357.0%

ROA (TTM)

RGNX-4604.0%

STTK-4090.0%

ROIC (TTM)

RGNX-7179.0%

STTK-4357.0%

Cash

RGNX$36M

STTK$63M

Debt

RGNX$182M

STTK$0

Net Cash/Debt

RGNX$-145M

STTK$63M

Current Ratio (TTM)

RGNX2.86x

STTK27.59x

Quick Ratio (TTM)

RGNX2.71x

STTK26.94x

Debt/Equity (TTM)

RGNX2.53x

STTK0.00x

Debt/Assets (TTM)

RGNX0.0%

STTK0.0%

Interest Coverage (TTM)

RGNXN/A

STTKN/A

Net Debt/EBITDA (TTM)

RGNX0.00x

STTK0.00x

Beta

RGNX1.21

STTK0.98

52W Performance

RGNX-34.0%

STTK149.8%

YTD Performance

RGNX-40.5%

STTK60.9%

% from 52W High

RGNX-50.2%

STTK-28.3%

% from 52W Low

RGNX47.9%

STTK251.2%

Asset Turnover (TTM)

RGNX0.41x

STTK0.01x

FCF Yield (TTM)

RGNX-48.9%

STTK-7.6%

Earnings Yield (TTM)

RGNX-38.5%

STTK-9.7%

Dividend Yield (TTM)

RGNXN/A

STTKN/A

Rule of 40

RGNX-131.1

STTK-4,190.6

EV/GP/RG

RGNX0.15

STTKN/A

Ticker research

View RGNX research View STTK research

Metric	RGNX Regenxbio Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$511M	$540M
Enterprise Value	$656M	$476M
Price	$8.07	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	2.93x	539.51x
EV/Sales	3.76x	476.21x
EV/EBITDA	5.30x	0.00x
P/B Ratio	6.83x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.63x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.95x	N/A
Revenue & Growth
Revenue (TTM)	$174M	$1M
Revenue Growth (YoY)	12.0%	-66.6%
Forward Rev Growth	25.9%	118.7%
Profitability
Gross Margin (TTM)	86.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-85.3%	-5212.2%
Net Margin (TTM)	-112.6%	-5256.8%
FCF Margin (TTM)	-143.1%	-4124.0%
Net Income (TTM)	$-196M	$-53M
FCF (TTM)	$-250M	$-41M
EPS (TTM)	-$3.71	-$0.41
ROE (TTM)	-22007.0%	-4357.0%
ROA (TTM)	-4604.0%	-4090.0%
ROIC (TTM)	-7179.0%	-4357.0%
Financial Health
Cash	$36M	$63M
Debt	$182M	$0
Net Cash/Debt	$-145M	$63M
Current Ratio (TTM)	2.86x	27.59x
Quick Ratio (TTM)	2.71x	26.94x
Debt/Equity (TTM)	2.53x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.98
52W Performance	-34.0%	149.8%
YTD Performance	-40.5%	60.9%
% from 52W High	-50.2%	-28.3%
% from 52W Low	47.9%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.41x	0.01x
FCF Yield (TTM)	-48.9%	-7.6%
Earnings Yield (TTM)	-38.5%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-131.1	-4,190.6
EV/GP/RG	0.15	N/A
Ticker research	View RGNX research	View STTK research

Valuation

P/S Ratio

RGNX

2.93x

STTK

539.51x

EV/FCF

STTK

-11.55x

RGNX

-2.63x

Growth & revenue

Revenue Growth TTM

RGNX

12.0%

STTK

-66.6%

Forward Revenue Growth

STTK

118.7%

RGNX

25.9%

Profitability & performance

Gross Margin

RGNX

86.4%

STTK

0.0%

ROE

STTK

-4357.0%

RGNX

-22007.0%

FCF Yield %

STTK

-7.6%

RGNX

-48.9%

52-Week Performance

STTK

149.8%

RGNX

-34.0%

Detailed metrics comparison

RGNX

Regenxbio Inc

STTK

Shattuck Labs Inc

Market Cap

RGNX$511M

STTK$540M

Enterprise Value

RGNX$656M

STTK$476M

Price

RGNX$8.07

STTK$5.97

P/E Ratio

RGNXN/A

STTKN/A

P/S Ratio

RGNX2.93x

STTK539.51x

EV/Sales

RGNX3.76x

STTK476.21x

EV/EBITDA

RGNX5.30x

STTK0.00x

P/B Ratio

RGNX6.83x

STTK3.20x

P/FCF Ratio

RGNXN/A

STTKN/A

EV/FCF

RGNX-2.63x

STTK-11.55x

PEG Ratio

RGNXN/A

STTKN/A

Forward P/E (NTM)

RGNXN/A

STTKN/A

Forward P/S (NTM)

RGNX5.95x

STTKN/A

Revenue (TTM)

RGNX$174M

STTK$1M

Revenue Growth (YoY)

RGNX12.0%

STTK-66.6%

Forward Rev Growth

RGNX25.9%

STTK118.7%

Gross Margin (TTM)

RGNX86.4%

STTK0.0%

Operating Margin (TTM)

RGNX0.0%

STTK0.0%

EBITDA Margin (TTM)

RGNX-85.3%

STTK-5212.2%

Net Margin (TTM)

RGNX-112.6%

STTK-5256.8%

FCF Margin (TTM)

RGNX-143.1%

STTK-4124.0%

Net Income (TTM)

RGNX$-196M

STTK$-53M

FCF (TTM)

RGNX$-250M

STTK$-41M

EPS (TTM)

RGNX-$3.71

STTK-$0.41

ROE (TTM)

RGNX-22007.0%

STTK-4357.0%

ROA (TTM)

RGNX-4604.0%

STTK-4090.0%

ROIC (TTM)

RGNX-7179.0%

STTK-4357.0%

Cash

RGNX$36M

STTK$63M

Debt

RGNX$182M

STTK$0

Net Cash/Debt

RGNX$-145M

STTK$63M

Current Ratio (TTM)

RGNX2.86x

STTK27.59x

Quick Ratio (TTM)

RGNX2.71x

STTK26.94x

Debt/Equity (TTM)

RGNX2.53x

STTK0.00x

Debt/Assets (TTM)

RGNX0.0%

STTK0.0%

Interest Coverage (TTM)

RGNXN/A

STTKN/A

Net Debt/EBITDA (TTM)

RGNX0.00x

STTK0.00x

Beta

RGNX1.21

STTK0.98

52W Performance

RGNX-34.0%

STTK149.8%

YTD Performance

RGNX-40.5%

STTK60.9%

% from 52W High

RGNX-50.2%

STTK-28.3%

% from 52W Low

RGNX47.9%

STTK251.2%

Asset Turnover (TTM)

RGNX0.41x

STTK0.01x

FCF Yield (TTM)

RGNX-48.9%

STTK-7.6%

Earnings Yield (TTM)

RGNX-38.5%

STTK-9.7%

Dividend Yield (TTM)

RGNXN/A

STTKN/A

Rule of 40

RGNX-131.1

STTK-4,190.6

EV/GP/RG

RGNX0.15

STTKN/A

Ticker research

View RGNX research View STTK research

Metric	RGNX Regenxbio Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$511M	$540M
Enterprise Value	$656M	$476M
Price	$8.07	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	2.93x	539.51x
EV/Sales	3.76x	476.21x
EV/EBITDA	5.30x	0.00x
P/B Ratio	6.83x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.63x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.95x	N/A
Revenue & Growth
Revenue (TTM)	$174M	$1M
Revenue Growth (YoY)	12.0%	-66.6%
Forward Rev Growth	25.9%	118.7%
Profitability
Gross Margin (TTM)	86.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-85.3%	-5212.2%
Net Margin (TTM)	-112.6%	-5256.8%
FCF Margin (TTM)	-143.1%	-4124.0%
Net Income (TTM)	$-196M	$-53M
FCF (TTM)	$-250M	$-41M
EPS (TTM)	-$3.71	-$0.41
ROE (TTM)	-22007.0%	-4357.0%
ROA (TTM)	-4604.0%	-4090.0%
ROIC (TTM)	-7179.0%	-4357.0%
Financial Health
Cash	$36M	$63M
Debt	$182M	$0
Net Cash/Debt	$-145M	$63M
Current Ratio (TTM)	2.86x	27.59x
Quick Ratio (TTM)	2.71x	26.94x
Debt/Equity (TTM)	2.53x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.21	0.98
52W Performance	-34.0%	149.8%
YTD Performance	-40.5%	60.9%
% from 52W High	-50.2%	-28.3%
% from 52W Low	47.9%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.41x	0.01x
FCF Yield (TTM)	-48.9%	-7.6%
Earnings Yield (TTM)	-38.5%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-131.1	-4,190.6
EV/GP/RG	0.15	N/A
Ticker research	View RGNX research	View STTK research